Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
THANK YOU, KRAMER!
(My understanding is that some like geno 3s would have to do 24 weeks.)
I'm gonna call them!
80/20 ....70/30......60/40 ...in Obamacare
If you are on the bottom or Bronze you will not get a treatment, or you got to fork 18k yourself. When already you only can afford Bronze the 18K could be a huge issue to put together. I see some storms on the horizon.The prices got to come down otherwise many people will ever be able to afford the treatments. For the $147 cost of 12 weeks there is lots a wiggle room for the Pharma.
in whole or part by Medicare, Medicaid, or any other federal or state-funded healthcare benefit program
by private plans or other health or pharmacy benefits programs that reimburse you for the entire cost of your prescription drugs"
So I wonder if these coupons are valid for a 24 week tx if it doesn't exceed the 20% of 12 week regime cost?
It does sound like the coupons are good with your insurance as long as your insurance doesn't pay the entire cost?
20% of $84,000 is $16,800
if they pay up to that amount that leaves $67,200
http://www.counselheal.com/articles/7882/20131207/fda-approves-new-treatment-for-hepatitis-c.htm
84.000 for 12 weeks.
The drug, sofosbuvir, which will be sold as Sovaldi, is manufactured by Gilead Sciences Inc. For some patients, the drug will be the first medication that can be taken for 12 weeks with one additional option and no interferon. Interferon is an injection that can lead to the development of flu-like symptoms. According to the FDA, patients with two strains of the virus called genotypes two and three will be able to take sofobuvir without interferon. Patients with the most common type, genotype one, would have to take sofosbuvir with interferon and ribavirin. Treatment for these patients could be up to 24 weeks.
I must be googling incorrectly.
http://www.forbes.com/sites/edsilverman/2013/11/11/will-the-new-hepatitis-c-drugs-trigger-a-battle-over-cost/
The analysis, which was displayed at the American Association for the Study of Liver Diseases gathering last week in Washington, DC, concluded that large-scale production of direct acting antivirals may be possible for as little as $100 to $200 for 12 weeks of treatment. The estimate cited HIV drugs, which initially cost tens of thousands of dollar per patient but have since dropped significantly in price in developing nations, as a model framework.
HCV DAA Patent expiry Class/daily dose Total dose (12 w) Predicted cost ($)
ribavirin generic NRTI/1200mg 84g $20-63
daclatasvir 2027 NS5a/60mg 5g $10-$30
sofosbuvir 2029 NtRTI/400mg 34g $68-$136
faldaprevir 2029 PI/120mg 10g $100-$210
simeprevir 2026 PI/150mg 13g $130-$270
[Predicted minimum cost per person of HCV DAAs]
Sofosbuvir for chronic hepatitis C with compensated liver disease
Disclaimer:
This report is work in progress and should not be used for external distribution without permission from the originating agency. Users should be aware that reports are based on information available at the time of research and often on a limited literature search.
Agent
Dose
Estimated cost for 12-week course
Ribavirin
1000mg
$21-63
Ribavirin
1200mg
$25-76
Daclatasvir
NS5a inhibitor
$10-30
Sofosbuvir
Nucleotide analogue, complex synthesis
$68-136
Faldaprevir
Protease inhibitor
$100-210
Simeprevir
Protease inhibitor: more complex structure
$130-270